DR. MICHAEL HENRY CYNAMON, M.D.
Osteopathic Medicine at Irving Ave, Syracuse, NY

6399607, Jun 4, 2002

Jun 30, 2000

09/607893

John T. Welch - Albany NY
Leonid B. Heifets - Denver CO
Michael H. Cynamon - Dewitt NY

Research Foundation-State University of New York - Rensselaer NY

A61K 3150

514247, 514 31, 5142521

Methods for treating diseases involving pyrazinamide-resistant mycobacteria comprise administering to a mammal in need of treatment a therapeutically effective amount of a combination of rifamycin and a compound of formula I: wherein R is hydrogen haloalkyl, or lower alkyl; R and R are independently chosen from alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, alkylaryl and substituted alkylaryl, or R and R taken together form a five- or six-membered heterocyclic or substituted heterocyclic ring; and X is hydrogen, halogen, or lower alkyl; or a pharmaceutically acceptable salt thereof.

5829696, Nov 3, 1998

Aug 27, 1997

8/921222

Michelle S. DeStefano - North Syracuse NY
Michael H. Cynamon - DeWitt NY
Donald W. Ziemendorf - Sanborn NY

B02C 1900

241169

An apparatus for grinding specimens, comprises a container, a grinder, a closure for the container, and a seal contained in the closure. The container has an interior grinding surface and contains an opening through which specimens are introduced for grinding. The grinder has a grinding head and an actuator arm extending from the grinding head. The grinding head is adapted to engage the interior grinding surface of the container. Grinding is effected by moving the grinding head against the grinding surface, using the actuator arm. The closure is adapted to close the container and enclose the grinding head therein. The closure contains a passage through which the actuator arm extends when the closure is enclosing the grinding head. The seal is contained in the closure and coaxially aligned with the passage of the closure, such that the actuator arm slidably engages the seal when the arm passes through the closure.

5643912, Jul 1, 1997

Jan 11, 1996

8/584707

Michael Henry Cynamon - Dewitt NY
John T. Welch - Albany NY

The Research Foundation of State University of NY - Albany NY

A61K 31495, C07D24118

514255

Compounds of formula II ##STR1## wherein R. sup. 1 is a hydrocarbon, halogenated hydrocarbon, polyether, substituted phenyl, substituted benzyl or alkylamine; and R. sup. 2, R. sup. 3 and R. sup. 4 are hydrogen, lower alkyl, halogen, haloalkyl, alkoxy and similar substituents are disclosed. The compounds are useful in the treatment of M. avium. Methods and compositions utilizing novel as well as known compounds are disclosed.

4962111, Oct 9, 1990

Jun 8, 1989

7/364067

John T. Welch - Albany NY
Michael H. Cynamon - Syracuse NY

The Research Foundation of State University of New York - Albany NY

A61K 31495, C07D24114, C07D24116, C07D24118

514255

Pyrazinoic esters have been prepared. Compounds of this group are effective against mycobacteria including Mycobacteria tuberculosis, pyrazinamide-resistant Mycobacteria tuberculosis, Mycobacteria bovis and Mycobacteria kansasii.

2012015, Jun 21, 2012

Nov 21, 2011

13/301128

John T. WELCH - Albany NY, US
Susana MENDEZ - Rockville MD, US
Michael H. CYNAMON - Dewitt NY, US

THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK - Albany NY
UNITED STATES GOVERMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR - Whasington DC
CORNELL UNIVERSITY - Ithaca NY

A61K 31/4965, A61K 31/7048, A61K 31/7036, A61P 37/04, A61K 31/496, A61K 31/541, A61K 31/555, A61P 33/02, A61K 31/69, A61K 31/661

514 31, 51425506, 514 64, 514 39, 514 77, 51425407, 5142278, 514184

Applicants claim the use of a pyrazine compound of formula I:or a salt thereof, for treating or preventing leishmaniases, and diseases and disorders caused by or and for inducing immunostimulation.

5816197, Oct 6, 1998

Oct 7, 1997

8/946259

Michelle S. DeStefano - North Syracuse NY
Michael H. Cynamon - DeWitt NY
Daniel F. Sammons - Liverpool NY

A61B 1900, A01K 1300

119712

An injection shield for protecting a person's hand during the injection of a needle into a rodent's tail. The shield comprises a frame which includes a coupler for a rodent restrainer, and contains an opening for a rodent's tail. The frame includes an injection surface on an injection side of the frame. The coupler is adapted to receive and releasably secure the restrainer in an orientation that permits the tail to be placed on the injection surface of the frame. The opening is dimensioned to allow the tail to pass through the frame, from the injection side to a shielded side. The opening is a sufficient distance from the coupler to allow the tail to extend through the opening and be grasped by the person's hand or otherwise secured. A method of protecting a person's hand during the injection of a needle into a rodent's tail is also contemplated by the present invention.